Advisory Board

Justin Caravaggio, MSc

Justin Caravaggio, MSc is an analyst, trader, and investor. He was recently an Analyst at Ernst & Young.
Justin coauthored Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice and Heat shock protein-27 attenuates foam cell formation and atherogenesis by down-regulating scavenger receptor-A expression via NF-κB signaling.
He was previously Laboratory Technician at University of Ottawa Heart Institute and Graduate Student / Lab Technician at University of Ottawa Heart Institute.
Justin earned his Bachelor’s of Science in Biochemistry at Bishop’s University in 2007. He earned his MSc in Cellular and Molecular Medicine at the University of Ottawa in 2010.
Read his LinkedIn profile.